Clinical Trials Directory

We are doing this study to collect blood donations from those who have HIV to make sure laboratories across the United States and other countries are testing their blood to know and help support the course of HIV and other infectious diseases of the immune system as well as look at possible vaccines.

We are doing this study to develop and test a nurse-delivered program for women who are experiencing premature and early menopause after cancer. The study's program includes personalized menopause health education and skills training to help manage menopause symptoms.

We are doing this study to compare 2 different approaches for patients who have surgery to remove non-small cell lung cancer (NSCLC). We want to see if giving patients an immunotherapy drug called durvalumab (the study drug) after surgery has different outcomes than the usual approach, which is to closely monitor a patient's condition for any changes.

We are doing this study to find out if images taken of the eye using a special type of camera placed inside a surgical microscope, called Microscope Integrated Optical Coherence Tomography (MIOCT), will give us new information during surgery that will improve both how we perform eye surgery and the results of surgery.

We are using this registry to learn more about acute aortic dissection from hospitals across the country.

We are doing this study to learn more about prostate cancer and whether certain treatments are related with different outcomes and patient experiences.

This study has 3 parts: 1. Screening - Lasts up to 28 days. You'll get heart tests, scans, and blood and urine tests. 2. Treatment - You'll be randomly picked to get either a new medicine (iza-bren) or a cancer medicine your doctor chooses. You'll visit the clinic 2-3 times every few weeks. 3. Follow-up - After treatment ends, you'll have: - A safety check 30 days later - Regular checkups every 12 weeks - More tests like scans and heart checks